Lupus patients in England in remission after pioneering NHS trial of GM therapy
Doctors say therapy that genetically modifies person’s T-cells could offer cure for chronic autoimmune disease Five lupus patients in England are in remission after being treated with a revolutionary therapy that genetically modifies their own cells, in a medical breakthrough that could offer people a cure, doctors have said. CAR (chimeric antigen receptor) T-cell therapy involves removing a type of white blood cell also called T lymphocytes, which are crucial for hunting out infected or damaged
Opening excerpt (first ~120 words) tap to expand
Katie Tinkler was one of the patients whose severe lupus went into remission after NHS trial of CAR T-cell therapy at University College London hospital. Photograph: Lucy North/PAView image in fullscreenKatie Tinkler was one of the patients whose severe lupus went into remission after NHS trial of CAR T-cell therapy at University College London hospital. Photograph: Lucy North/PAMedical researchLupus patients in England in remission after pioneering NHS trial of GM therapyDoctors say therapy that genetically modifies person’s T-cells could offer cure for chronic autoimmune diseaseAndrew Gregory Health editorThu 11 Jun 2026 19.01 EDTSharePrefer the Guardian on GoogleFive lupus patients in England are in remission after being treated with a revolutionary therapy that genetically modifies…
Excerpt limited to ~120 words for fair-use compliance. The full article is at the Guardian.
Discussion
0 commentsMore from the Guardian
